Literature DB >> 21110882

Knowledge and acceptability of the rectal treatment route in Laos and its application for pre-referral emergency malaria treatment.

Southisouk Inthavilay1, Thierry Franchard, Yang Meimei, Elizabeth A Ashley, Hubert Barennes.   

Abstract

BACKGROUND: Rectal artesunate has been shown to reduce death and disability from severe malaria caused by delays in reaching facilities capable of providing appropriate treatment. Acceptability of this mode of drug delivery in Laos is not known. In 2009 the acceptability of rectal treatments was evaluated among the general Lao population and Lao doctors in a national survey.
METHODS: A cross sectional survey was performed of 985 households selected through a multi-stage random sampling process from 85 villages in 12/18 provinces and of 315 health staff randomly selected at each administrative level.
RESULTS: Out of 985 families, 9% had used the rectal route to treat children (the main indication was seizures or constipation). The population considered it less effective than other routes. Other concerns raised included pain (28%), discomfort for children (40%) and the possibility of other side effects (20%). Of 300 health staff surveyed (nurses 44%, doctors 66%), only 51% had already used the rectal route with a suppository, mostly to treat fever (76%). Health staff working in provincial hospitals had more experience of using the rectal route than those in urban areas. The majority (92%) were keen to use the rectal route to treat malaria although oral and intramuscular routes were preferred and considered to be more efficacious. DISCUSSION AND
CONCLUSION: Use of rectal treatments is uncommon in Laos and generally not considered to be very effective. This view is shared by the population and health care workers. More information and training are needed to convince the population and health staff of the efficacy and advantages of the rectal route for malaria treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110882      PMCID: PMC3002379          DOI: 10.1186/1475-2875-9-342

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  13 in total

1.  Treating severe malaria.

Authors:  Christopher J M Whitty; Evelyn Ansah; Hugh Reyburn
Journal:  BMJ       Date:  2005-02-12

Review 2.  Rectal administration of artemisinin derivatives for the treatment of malaria.

Authors:  Harin A Karunajeewa; Laurens Manning; Ivo Mueller; Kenneth F Ilett; Timothy M E Davis
Journal:  JAMA       Date:  2007-06-06       Impact factor: 56.272

3.  Diagnosis and management of malaria by rural community health providers in the Lao People's Democratic Republic (Laos).

Authors:  Mayfong Mayxay; Tiengkham Pongvongsa; Samlane Phompida; Rattanaxay Phetsouvanh; Nicholas J White; Paul N Newton
Journal:  Trop Med Int Health       Date:  2007-04       Impact factor: 2.622

4.  An open randomized clinical study of intrarectal versus infused Quinimax for the treatment of childhood cerebral malaria in Niger.

Authors:  H Barennes; J Munjakazi; F Verdier; F Clavier; E Pussard
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Jul-Aug       Impact factor: 2.184

5.  Is it too soon to eliminate quinine?

Authors:  Hubert Barennes; Leila M Srour; Eric Pussard
Journal:  Lancet Infect Dis       Date:  2010-03       Impact factor: 25.071

6.  [Traditional enema for newborns and infants in Bobo Dioulasso: health practice or socialisation].

Authors:  Pierre Huygens; Blahima Konaté; Abdullaye Traoré; Hubert Barennes
Journal:  Sante       Date:  2002 Oct-Dec

7.  Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial.

Authors:  Hubert Barennes; Tatiana Balima-Koussoubé; Nicolas Nagot; Jean-Christophe Charpentier; Eric Pussard
Journal:  BMJ       Date:  2006-05-06

8.  Understanding caretakers' dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunate.

Authors:  Daudi O Simba; Deodatus C Kakoko; Marian Warsame; Zul Premji; Melba F Gomes; Goran Tomson; Eva Johansson
Journal:  Malar J       Date:  2010-05-12       Impact factor: 2.979

9.  Factors influencing adherence to referral advice following pre-referral treatment with artesunate suppositories in children in rural Tanzania.

Authors:  Daudi O Simba; Marian Warsame; Omari Kimbute; Deodatus Kakoko; Max Petzold; Goran Tomson; Zul Premji; Melba Gomes
Journal:  Trop Med Int Health       Date:  2009-05-26       Impact factor: 2.622

10.  A qualitative study to identify community structures for management of severe malaria: a basis for introducing rectal artesunate in the under five years children in Nakonde District of Zambia.

Authors:  Frederick A D Kaona; Mary Tuba
Journal:  BMC Public Health       Date:  2005-03-25       Impact factor: 3.295

View more
  4 in total

Review 1.  Pre-referral rectal artesunate for severe malaria.

Authors:  Joseph Okebe; Michael Eisenhut
Journal:  Cochrane Database Syst Rev       Date:  2014-05-29

2.  Introducing the concept of a new pre-referral treatment for severely ill febrile children at community level: a sociological approach in Guinea-Bissau.

Authors:  Audrey Vermeersch; Anaëlle Libaud-Moal; Amabelia Rodrigues; Nicholas J White; Piero Olliaro; Melba Gomes; Elizabeth A Ashley; Pascal Millet
Journal:  Malar J       Date:  2014-02-06       Impact factor: 2.979

Review 3.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

4.  Adherence to the referral advice after introduction of rectal artesunate for pre-referral treatment of severe malaria at the community level: a noninferiority trial in the Democratic Republic of the Congo.

Authors:  Patrick M Mvumbi; Jeanine Musau; Ousmane Faye; Hyppolite Situakibanza; Emile Okitolonda
Journal:  Malar J       Date:  2019-12-21       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.